Research Article
Diagnostic Value of CD25, CD69, and CD134 on Tuberculosis-Specific Antigen-Stimulated CD4+ T Cells for Tuberculous Pleurisy
Table 3
The diagnostic efficacy of activation indexes and routine laboratory methods for ATB diagnosis.
| Variables | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | Accuracy (%) |
| Xpert MTB/RIF | 62.2% (46.5%–75.8%) | 100.0% (89.6%–100.0%) | 100.0% (85%–100.0%) | 71.2% (57.7%–82.0%) | 80.5 | Acid-fast bacilli smear | 44.4% (30.0%–59.9%) | 100.0% (89.6%–100.0%) | 100.0% (98%–100.0%) | 62.7% (50.0%–73.9%) | 71.3 | Mtb culture | 48.9% (33.9%–64.0%) | 100.0% (89.6%–100.0%) | 100.0% (81.5%–100.0%) | 64.6% (51.7%–75.8%) | 73.6 | TB-IGRA | 95.6% (83.6%–99.2%) | 90.5% (76.5%–96.9%) | 91.5% (78.7%–97.2%) | 95.0% (81.8%–99.1%) | 93.1 | CD25+ | 86.7% (72.5%–94.5%) | 78.6% (62.8%–89.2%) | 81.3% (66.9%–90.6%) | 84.6% (68.8%–93.6%) | 82.8 | CD69+ | 86.7% (72.5%–94.5%) | 78.6% (62.8%–89.2%) | 81.3% (66.9%–90.6%) | 84.6% (68.8%–93.6%) | 82.8 | CD134+ | 88.9% (75.2%–95.8%) | 76.2% (60.2%–87.4%) | 80.0% (65.9%–89.5%) | 86.5% (70.4%–94.9%) | 82.8 | CD25+CD69+ | 84.4% (69.9%–93.0%) | 83.3% (68.0%–92.5%) | 84.4% (69.9%–93%) | 83.3% (68.0%–92.5%) | 83.9 | CD25+CD134+ | 86.7% (72.5%–94.5%) | 83.3% (68.0%–92.5%) | 84.8% (70.5%–93.2%) | 85.4% (70.1%–93.9%) | 85.1 | CD69+CD134+ | 86.7% (72.5%–94.5%) | 83.3% (68.0%–92.5%) | 84.8% (70.5%–93.2%) | 85.4% (70.1%–93.9%) | 85.1 |
|
|